辅助Scepter Mini球囊微导管脑膜中动脉栓塞加速慢性硬膜下血肿清除的多中心匹配队列研究
该回顾性多中心匹配队列研究纳入22例(38个血肿)慢性硬膜下血肿患者,在钻孔引流后行辅助性脑膜中动脉栓塞(使用Scepter Mini双腔球囊微导管和Onyx 18),与22例匹配的单纯钻孔引流历史对照(38个血肿)比较。结果显示栓塞组所有血肿达到MMA-EPS 3或4级,6个月内完全影像学吸收(厚度0.0±0.0 mm vs 对照组0.7±0.9 mm),6个月良好功能预后(mRS 0-2)率为86.4% vs 45.5%,且复发率和全因死亡率数值上更低,技术成功率高且无重大并发症。
要点
- 辅助性脑膜中动脉栓塞可加速慢性硬膜下血肿的影像学吸收,6个月时完全吸收。
- MMA-EPS分级3-4级提示栓塞剂渗透至远端,与血肿完全吸收相关。
- 6个月良好功能预后(mRS 0-2)在栓塞组为86.4%,高于对照组的45.5%。
关键影像表现/征象
- 栓塞组所有血肿均达到MMA-EPS 3或4级,提示栓塞剂渗透至远端。
- 栓塞组6个月时血肿完全吸收(厚度0.0±0.0 mm),对照组仍有残留(0.7±0.9 mm)。
- 复发率(4.5% vs 13.6%)和全因死亡率(0% vs 13.6%)在栓塞组数值上更低,但研究未针对这些终点设计统计效能。
诊断标准与关键数值
- MMA-EPS(脑膜中动脉栓塞渗透评分)分级3或4级表示远端栓塞渗透,栓塞组全部达到。
- 6个月良好功能预后定义为mRS 0-2,栓塞组86.4%,对照组45.5%。
- 复发率栓塞组4.5%,对照组13.6%;全因死亡率栓塞组0%,对照组13.6%(差异未作统计检验)。
临床应用与阅片要点
- 在慢性硬膜下血肿钻孔引流后,可考虑辅助脑膜中动脉栓塞以促进血肿吸收。
- 使用Scepter Mini双腔球囊微导管行栓塞时,关注MMA-EPS分级,3-4级提示栓塞剂渗透良好。
- 随访CT显示栓塞组血肿消退更快,报告时应注意描述血肿厚度变化和吸收情况。
- 尽管并发症少,但需注意本研究样本量小,结果需谨慎应用于个体化决策。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 样本量小(22对匹配),研究未针对复发率和死亡率等终点设计统计效能。
- 使用历史对照,非同期随机对照。
- 单中心使用特定器械和栓塞材料,结果外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the radiographic and clinical outcomes of adjunctive middle meningeal artery embolization (MMAE) performed with the Scepter Mini dual-lumen balloon microcatheter following burr-hole evacuation for chronic subdural hematoma (cSDH), and to explore the feasibility of characterizing distal embolic penetration using the proposed MMA Embolization Penetration Score (MMA-EPS).
METHODS: This retrospective multicenter matched cohort study included consecutive patients with cSDH treated with burr-hole evacuation followed by adjunctive MMAE using the Scepter Mini and Onyx™ 18. A matched historical cohort treated with burr-hole evacuation alone served as controls. The primary endpoint was longitudinal hematoma thickness regression on serial computed tomography. Secondary endpoints included functional outcome, recurrence, all-cause mortality, and procedural safety.
RESULTS: Twenty-two patients with 38 embolized cSDHs were compared with 22 matched controls comprising 38 cSDHs. All embolized hematomas achieved MMA-EPS Grade 3 or 4 and demonstrated complete radiographic resolution by 6 months, whereas residual hematoma persisted in controls (0.0 ± 0.0 vs. 0.7 ± 0.9 mm). Favorable functional outcome (mRS 0-2) at 6 months was achieved in 86.4% versus 45.5% of patients. Exploratory analyses showed numerically lower recurrence (4.5% vs. 13.6%) and all-cause mortality (0% vs. 13.6%) following MMAE; however, the study was not powered to assess differences in these endpoints. Technical success was achieved in all embolizations without major procedure-related complications.
CONCLUSION: Adjunctive MMAE using the Scepter Mini dual-lumen balloon microcatheter was associated with accelerated hematoma resolution, improved functional recovery, and an excellent procedural safety profile compared with burr-hole evacuation alone.
引用
- Alheer M, Sporns PB, Broocks G, et al. Longitudinal hematoma resolution after burr-hole evacuation with adjunctive scepter mini-assisted middle meningeal artery embolization: A multicenter matched cohort study. Neuroradiology. 2026. PMID: 42873297. doi:10.1007/s00234-026-04203-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。